News Releases

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
March 16, 2022
Significant progress achieved in 2021: Pipeline now includes six internally discovered small molecule compounds targeting clinically validated pathways in cancers with underserved patients Objectives for 2022: Focused on demonstrating proof-of-concept clinical data for lead pipeline compounds and